Icosapent ethyl
Tier C — Watch / tradeIcosapent ethyl
Targets：PPARα
Brand：VAZKEPA, Solmiran, Epadel, Vascepa, Miraxion
Indications (approved)：Hypertriglyceridaemia, Cardiac and vascular disorders, Dyslipidaemia, 闭塞性动脉硬化, Hyperlipidaemia
Regional status
Factories producing this API1
Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.
1 producing factories on file — sign in to view the named list (factory details are not shown to guests).
Sign in to view factories →Synthetic routes & intermediates
Frequently asked questions
What are the approved indications of Icosapent ethyl?
Approved indications include: Hypertriglyceridaemia, Cardiac and vascular disorders, Dyslipidaemia, 闭塞性动脉硬化, Hyperlipidaemia.
When does the Icosapent ethyl patent expire?
No public expiry year is available for Icosapent ethyl yet; this page updates once verified.
How do I get a quote for Icosapent ethyl intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27